Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. - Wikidata - wikimedia - TriplyDB

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

http://www.wikidata.org/entity/Q33915820

about

Prevention of Alzheimer's disease The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein Autosomal recessive hypercholesterolemia protein interacts with and regulates the cell surface level of Alzheimer's amyloid beta precursor protein Oleuropein in olive and its pharmacological effects Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts Authors' Reply A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease.Linking lipids, Alzheimer's and LXRs?The amyloid hypothesis of Alzheimer's disease at 25 years The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease Statins, cognition, and dementia—systematic review and methodological commentary Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome Oxidized cholesterol as the driving force behind the development of Alzheimer's disease Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease Dynamics and Cleavability at the alpha-cleavage site of APP(684-726) in different lipid environments Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse model ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage Towards understanding brain-gut-microbiome connections in Alzheimer's disease Alzheimer disease models and human neuropathology: similarities and differences A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease Novel imaging strategies for assessment of cerebrovascular involvement.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Amyloid-β metabolism in Niemann-Pick C disease models and patients.Cholesterol-modifying strategies for Alzheimer's disease.Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's Disease Use of genetic variation as biomarkers for Alzheimer's disease.Higher incidence of mild cognitive impairment in familial hypercholesterolemia.The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice.Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.A comparative study on the effect of high cholesterol diet on the hippocampal CA1 area of adult and aged rats.

P2860

Q22248031-0A7E15FF-9FD0-4C7C-967C-6320DE645BF2 Q24296758-693E5587-3A4B-4485-BB91-280F1D6239BE Q24305128-4BFCA206-E228-43BB-BDB6-A28E94D68412 Q24628912-0675EC7D-3C64-4B02-8FC7-D9A5EA81F132 Q24630927-CBC2428E-5E9A-482E-BBEE-3A41ACBBECEC Q24675729-F0A44C6C-93F4-4FD5-9BBF-A3708D1543BC Q24805578-2795CC04-1BC3-41D8-B815-CCD262C88737 Q24816672-084F1624-E2EA-4AD9-AA80-7D8B4E5B0B35 Q25255165-7E767332-3035-41A5-97D5-6491650A895B Q26749528-FD285B63-BF1F-4ACB-985C-8B77C9C1B594 Q26777969-C4794600-B786-46F7-8988-FCF1169DF5EF Q26852778-885C04DC-62AF-4B66-9D46-8535711A844E Q27008997-5B72A10E-FB62-45E6-9ECD-57FD8201E33D Q27023315-B42438E8-B244-4D3D-88CD-A3419975BBE2 Q27310276-B20A4436-6958-465C-BA79-A7273F92248A Q27315066-945877CB-D98B-46A2-B530-2D69D43226ED Q28074531-563A0236-DEC1-4BEC-9776-5D91A854C98F Q28081654-92A8E343-042E-4188-A4A7-A1575AAFBE3D Q28384987-25CA328A-41E3-47E5-BE0E-4F35D099BB70 Q28485899-1E8701F8-E25E-4CB9-BA3D-84114DC8FE2F Q28504715-212A4A63-C795-48DD-9D0C-3BA007779880 Q28742107-A0CA5B99-6B47-460B-A66C-76252D6FF34C Q28831443-AA6F00A7-B90C-4E00-B9D5-6B6C95248B68 Q30499574-DE3044BE-64C4-4AE5-88FA-77F58D5354F0 Q30538459-97DC0B77-EC46-40DA-BF58-DDD35B0DC283 Q30581572-8A603B06-DF22-47ED-90A3-C482011DA143 Q30814231-DE670A17-5A09-46B5-A61F-6859345BF3F2 Q31047131-39BEE6C7-9CBF-4A68-B791-890B8E375518 Q31088092-6509634A-0397-4BEF-925D-A2096CE9F2E1 Q33347051-F21ACFBA-4D3D-4A9A-A121-DF43A435D3B5 Q33556064-66FA010A-761E-47FE-A964-1AB1CF3D5941 Q33584772-5D6FF454-878B-432A-A962-B1DA1651D59B Q33631144-85139FF5-611C-4D2C-B215-07DF659434C0 Q33640956-20FF346C-90CF-4CCF-8E89-11F3397C64A1 Q33750064-0E6F3801-3874-4C41-974C-663F8E439DAB Q33768345-3670F05D-BF0F-4B11-BCA4-504EFA4DDDA6 Q33770606-A213C8AF-1DBB-4C9A-8FB6-224A0A6182EF Q33791780-3611E734-F25C-4601-92AF-2A46EACCAE85 Q33811355-01F2E013-DD3D-46EE-9317-E33C8F6C7DB4 Q33826395-F3BC3F75-BC07-475A-9097-D85769118271

P2860

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

http://www.wikidata.org/entity/Q33915820

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@ast

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@en

type

label

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@ast

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@en

prefLabel

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@ast

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@en

P1433

Q33915820-A046FE4A-8429-4C88-B9AB-CEDB4039954E

P1476

Q33915820-5C6BF6D4-7AEE-4B29-B720-F5F23917F1F7

P2093

Q33915820-05501C95-3BAF-46CA-9F21-20DB1B06C214

Q33915820-2439C550-4A56-41E1-9398-0EBFA53E58F8

Q33915820-39B354F2-CA12-4722-91B5-D41B6296E431

Q33915820-76CAEDF4-A3C5-4EB7-89BA-19375F75CC8C

Q33915820-892C3ED4-C5A8-4367-A881-B5635D367704

Q33915820-9CD41B30-A02E-462F-A69D-66119F2C61FF

Q33915820-A3713950-F64B-49D8-AED1-7FA088BDB826

Q33915820-C05CF737-7DA0-49B7-BD93-EA85B43EE3DC

Q33915820-FAA0CB4A-07D2-4726-8D5D-59D25BBF0426

P304

Q33915820-01C960BA-60A2-4F1F-BAFF-4FEF48E82EDA

P31

Q33915820-E279F39C-5CF8-4C4B-80A8-65B984CDE1D9

P356

Q33915820-B2E00244-147D-48E2-A110-C950FC183DEC

P433

Q33915820-5C170770-A576-4E7B-86A6-7477A3ADF54B

P478

Q33915820-D777A9E8-B8F5-496A-8D91-45FB23FDB18B

P577

Q33915820-866B90AA-7E7C-4057-8A31-9E2AA3C013A3

P698

Q33915820-26A61625-E949-43BB-BA40-4F0B52FF5472

P921

Q33915820-8F19AD02-A010-4407-BE50-CCCE0A842273

Q33915820-F4FC0E0E-F2C8-4AB1-9C56-A7E8290A185C

Q33915820-fb5763dd-cacb-4e2a-8da2-d6cc0076965e

P356

P1433

Neurobiology of Disease

P1476

Hypercholesterolemia accelerat ...... y in a transgenic mouse model.

@en

P2093

Bryant-Thomas T

http://www.w3.org/2001/XMLSchema#string

Duff K

http://www.w3.org/2001/XMLSchema#string

LaFrancois J

http://www.w3.org/2001/XMLSchema#string

Malester B

http://www.w3.org/2001/XMLSchema#string

Pappolla MA

http://www.w3.org/2001/XMLSchema#string

Refolo LM

http://www.w3.org/2001/XMLSchema#string

Sambamurti K

http://www.w3.org/2001/XMLSchema#string

Tint GS

http://www.w3.org/2001/XMLSchema#string

Wang R

http://www.w3.org/2001/XMLSchema#string

P304

321-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1006/NBDI.2000.0304

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10964604

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

hypercholesterolemia